MicroRNAs in cardiovascular diseases: Current knowledge and the road ahead

Journal of the American College of Cardiology

Volumn 63, Issue 21, 2014, Pages 2177-2187

  Condorelli, Gianluigi ^a,b,c   Latronico, Michael V G ^a   Cavarretta, Elena ^d  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Milan Unit   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

cardiovascular disease; heart disease; microRNA

Indexed keywords

MICRORNA; MICRORNA 122; MICRORNA 1228; MICRORNA 126; MICRORNA 132; MICRORNA 133; MICRORNA 145; MICRORNA 15; MICRORNA 192; MICRORNA 194; MICRORNA 199A; MICRORNA 200B; MICRORNA 208A; MICRORNA 21; MICRORNA 210; MICRORNA 212; MICRORNA 22; MICRORNA 24; MICRORNA 29B; MICRORNA 30A; MICRORNA 320; MICRORNA 320A; MICRORNA 328; MICRORNA 33; MICRORNA 34A; MICRORNA 423 5P; MICRORNA 590; MICRORNA 622; MICRORNA 92B; UNCLASSIFIED DRUG; ADENOVIRUS VECTOR; ANTAGOMIR; ANTISENSE OLIGONUCLEOTIDE; LENTIVIRUS VECTOR; MICRORNA 1; MICRORNA 143; MICRORNA 146A; MICRORNA 155; MICRORNA 15A; MICRORNA 16; MICRORNA 17 3P; MICRORNA 181; MICRORNA 199A 3P; MICRORNA 221; MICRORNA 222; MICRORNA 29; MICRORNA 31; MICRORNA 499; MICRORNA 503; MICRORNA 590 3P; UNINDEXED DRUG;

ABDOMINAL AORTA ANEURYSM; ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ANGIOGENESIS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CEREBROVASCULAR ACCIDENT; CONGESTIVE CARDIOMYOPATHY; DIABETES MELLITUS; DISEASE COURSE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MYOCARDIAL DISEASE; MYOCARDITIS; NONHUMAN; PATHOGENESIS; PERIPHERAL ISCHEMIA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REGULATORY MECHANISM; SMOOTH MUSCLE FIBER; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE; AORTA ANEURYSM; BRAIN ISCHEMIA; CARDIOMYOPATHY; CARDIOVASCULAR MAGNETIC RESONANCE; CELL THERAPY; DIABETIC ANGIOPATHY; DIAGNOSTIC VALUE; DRUG EFFECT; DYSLIPIDEMIA; FATTY LIVER; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; HEART DEVELOPMENT; HEART INFARCTION; HEART MUSCLE FIBROSIS; HEPATITIS C; LIMB ISCHEMIA; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PROGNOSIS; RESTENOSIS; SENSITIVITY AND SPECIFICITY; SUBRETINAL NEOVASCULARIZATION; TAKOTSUBO CARDIOMYOPATHY;

CARDIOVASCULAR DISEASE; HEART DISEASE; MICRORNA;

ANIMALS; CARDIOVASCULAR DISEASES; GENETIC THERAPY; HUMANS; MICRORNAS;

EID: 84899658554     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.01.050     Document Type: Review

References (135)

1. E. Pennisi ENCODE Project writes euology for junk dNA Science 337 2012 1159 1161
2. J.S. Mattick, and I.V. Makunin Non-coding RNA Hum Mol Genet 15 Spec No 1 2006 R17 R29
3. J.S. Mattick Non-coding RNAs: the architects of eukaryotic complexity EMBO Rep 21 2001 986 991
4. V. Pachnis, C.I. Brannan, and S.M. Tilghman The structure and expression of a novel gene activated in early mouse embryogenesis EMBO J 7 1988 673 681
5. M. Guttman, and J.L. Rinn Modular regulatory principles of large non-coding RNAs Nature 482 2012 339 346
6. A.K. Leung, and P.A. Sharp MicroRNA functions in stress responses Mol Cell 40 2010 205 215
7. D.P. Bartel MicroRNAs: target recognition and regulatory functions Cell 136 2009 215 233
8. I. Rigoutsos New tricks for animal microRNAS: targeting of amino acid coding regions at conserved and nonconserved sites Cancer Res 69 2009 3245 3248
9. R.C. Friedman, K.K. Farh, C.B. Burge, and D.P. Bartel Most mammalian mRNAs are conserved targets of microRNAs Genome Res 19 2009 92 105
10. A. Kozomara, and S. Griffiths-Jones miRBase: integrating microRNA annotation and deep-sequencing data Nucleic Acids Res 39 2011 D152 D157
11. Y. Liang, D. Ridzon, L. Wong, and C. Chen Characterization of microRNA expression profiles in normal human tissues BMC Genomics 8 2007 166
12. Y. Hu Epitranscriptional orchestration of genetic reprogramming is an emergent property of stress-regulated cardiac microRNAs PNAS 109 2012 19864 19869
13. S.J. Matkovich, Y. Hu, and G.W. Dorn 2nd Regulation of cardiac microRNAs by cardiac microRNAs Circ Res 113 2013 62 71
14. R. Kumarswamy, and T. Thum Non-coding RNAs in cardiac remodeling and heart failure Circ Res 113 2013 676 689
15. G. Zardo, A. Ciolfi, and L. Vian et al. Transcriptional targeting by microRNA-polycomb complexes: a novel route in cell fate determination Cell Cycle 11 2012 3543 3549
16. G. Zardo, A. Ciolfi, and L. Vian et al. Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expression Blood 119 2012 4034 4046
17. E.E. Creemers, A.J. Tijsen, and Y.M. Pinto Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res 110 2012 483 495
18. R.C. Lee, R.L. Feinbaum, and V. Ambros The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 Cell 75 1993 843 854
19. B. Wightman, I. Ha, and G. Ruvkun Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans Cell 75 1993 855 862
20. G.A. Calin, C.D. Dumitru, and M. Shimizu et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia Proc Natl Acad Sci U S A 99 2002 15524 15529
21. J.T. Mendell, and E.N. Olson MicroRNAs in stress signaling and human disease Cell 148 2012 1172 1187
22. C. Kwon, Z. Han, E.N. Olson, and D. Srivastava MicroRNA1 influences cardiac differentiation in Drosophila and regulates Notch signaling Proc Natl Acad Sci U S A 102 2005 18986 18991
23. Y. Zhao, J.F. Ransom, and A. Li et al. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2 Cell 129 2007 303 317
24. E. van Rooij, L.B. Sutherland, X. Qi, J.A. Richardson, J. Hill, and E.N. Olson Control of stress-dependent cardiac growth and gene expression by a microRNA Science 316 2007 575 579
25. A. Carè, D. Catalucci, and F. Felicetti et al. MicroRNA-133 controls cardiac hypertrophy Nat Med 13 2007 613 618
26. L. Elia, R. Contu, and M. Quintavalle et al. Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions Circulation 120 2009 2377 2385
27. F. Varrone, B. Gargano, and P. Carullo et al. The circulating level of FABP3 is an indirect biomarker of microRNA-1 J Am Coll Cardiol 61 2013 88 95
28. T. Thum, C. Gross, and J. Fiedler et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts Nature 456 2008 980 984
29. E. van Rooij, L.B. Sutherland, and J.E. Thatcher et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis Proc Natl Acad Sci U S A 105 2008 13027 13032
30. S. Wang, A.B. Aurora, and B.A. Johnson et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis Dev Cell 15 2008 261 271
31. P.A. da Costa Martins, K. Salic, and M.M. Gladka et al. MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling Nat Cell Biol 12 2010 1220 1227
32. E. Dirkx, M.M. Gladka, and L.E. Philippen et al. Nfat and miR-25 cooperate to reactivate the transcription factor Hand2 in heart failure Nat Cell Biol 15 2013 1282 1293
33. H. el Azzouzi, S. Leptidis, and E. Dirkx et al. The Hypoxia-Inducible MicroRNA Cluster miR-199a∼214 Targets Myocardial PPARδ and Impairs Mitochondrial Fatty Acid Oxidation Cell Metab 18 2013 341 354
34. J. Ganesan, D. Ramanujam, and Y. Sassi et al. MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors Circulation 127 2013 2097 2106
35. R.A. Boon, K. Iekushi, and S. Lechner et al. MicroRNA-34a regulates cardiac ageing and function Nature 495 2013 107 110
36. S. Heymans, M.F. Corsten, and W. Verhesen et al. Macrophage microRNA-155 promotes cardiac hypertrophy and failure Circulation 128 2013 1420 1432
37. S.J. Matkovich, Y. Hu, W.H. Eschenbacher, L.E. Dorn, and G.W. Dorn 2nd Direct and indirect involvement of microRNA-499 in clinical and experimental cardiomyopathy Circ Res 111 2012 521 531
38. A. Eulalio, M. Mano, and M. Dal Ferro et al. Functional screening identifies miRNAs inducing cardiac regeneration Nature 492 2012 376 381
39. S.A. Asgeirsdottir, C. van Solingen, and N.F. Kurniati et al. MicroRNA-126 contributes to renal microvascular heterogeneity of VCAM-1 protein expression in acute inflammation Am J Physiol Renal Physiol 302 2012 F1630 F1639
40. J. Madrigal-Matute, N. Rotllan, J.F. Aranda, and C. Fernandez-Hernando MicroRNAs and atherosclerosis Curr Atheroscler Rep 15 2013 322
41. X. Sun, B. Icli, and A.K. Wara et al. MicroRNA-181b regulates NF-kappaB-mediated vascular inflammation J Clin Invest 122 2012 1973 1990
42. C. Esau, S. Davis, and S.F. Murray et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting Cell Metab 3 2006 87 98
43. J. Elmen, M. Lindow, and A. Silahtaroglu et al. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver Nucleic Acids Res 36 2008 1153 1162
44. S.H. Najafi-Shoushtari, F. Kristo, and Y. Li et al. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis Science 328 2010 1566 1569
45. K.J. Rayner, Y. Suarez, and A. Davalos et al. MiR-33 contributes to the regulation of cholesterol homeostasis Science 328 2010 1570 1573
46. T.J. Marquart, R.M. Allen, D.S. Ory, and A. Baldan miR-33 links SREBP-2 induction to repression of sterol transporters Proc Natl Acad Sci U S A 107 2010 12228 12232
47. R.S. Huang, G.Q. Hu, B. Lin, Z.Y. Lin, and C.C. Sun MicroRNA-155 silencing enhances inflammatory response and lipid uptake in oxidized low-density lipoprotein-stimulated human THP-1 macrophages J Investig Med 58 2010 961 967
48. T. Chen, Z. Huang, and L. Wang et al. MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte/macrophages Cardiovasc Res 83 2009 131 139
49. K.C. Chen, Y.S. Wang, and C.Y. Hu et al. OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular diseases FASEB J 25 2011 1718 1728
50. F. Lovren, Y. Pan, and A. Quan et al. MicroRNA-145 targeted therapy reduces atherosclerosis Circulation 126 Suppl 1 2012 S81 S90
51. P. Dentelli, A. Rosso, F. Orso, C. Olgasi, D. Taverna, and M.F. Brizzi microRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression Arterioscler Thromb Vasc Biol 30 2010 1562 1568
52. M. Nazari-Jahantigh, Y. Wei, and H. Noels et al. MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages J Clin Invest 122 2012 4190 4202
53. Y. Wei, M. Nazari-Jahantigh, and L. Chan et al. The microRNA-342-5p fosters inflammatory macrophage activation through an Akt1- and microRNA-155-dependent pathway during atherosclerosis Circulation 127 2013 1609 1619
54. Y. Suarez, C. Fernandez-Hernando, and J. Yu et al. Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis Proc Natl Acad Sci U S A 105 2008 14082 14087
55. K.R. Cordes, N.T. Sheehy, and M.P. White et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity Nature 460 2009 705 710
56. M. Xin, E.M. Small, and L.B. Sutherland et al. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury Genes Dev 23 2009 2166 2178
57. T. Boettger, N. Beetz, and S. Kostin et al. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster J Clin Invest 119 2009 2634 2647
58. L. Elia, M. Quintavalle, and J. Zhang et al. The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease Cell Death Differ 16 2009 1590 1598
59. Y. Cheng, X. Liu, and J. Yang et al. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation Circ Res 105 2009 158 166
60. P. Caruso, Y. Dempsie, and H.C. Stevens et al. A role for miR-145 in pulmonary arterial hypertension: evidence from mouse models and patient samples Circ Res 111 2012 290 300
61. X. Liu, Y. Cheng, S. Zhang, Y. Lin, J. Yang, and C. Zhang A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia Circ Res 104 2009 476 487
62. P. Li, N. Zhu, and B. Yi et al. MicroRNA-663 regulates human vascular smooth muscle cell phenotypic switch and vascular neointimal formation Circ Res 113 2013 1117 1127
63. D. Torella, C. Iaconetti, and D. Catalucci et al. MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo Circ Res 109 2011 880 893
64. A. Bonauer, G. Carmona, and M. Iwasaki et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice Science 324 2009 1710 1713
65. K. Iekushi, F. Seeger, B. Assmus, A.M. Zeiher, and S. Dimmeler Regulation of cardiac microRNAs by bone marrow mononuclear cell therapy in myocardial infarction Circulation 125 2012 1765 1773 S1-7
66. Q. Xu, F.H. Seeger, and J. Castillo et al. Micro-RNA-34a contributes to the impaired function of bone marrow-derived mononuclear cells from patients with cardiovascular disease J Am Coll Cardiol 59 2012 2107 2117
67. G. Spinetti, D. Cordella, and O. Fortunato et al. Global remodeling of the vascular stem cell niche in bone marrow of diabetic patients: implication of the microRNA-155/FOXO3a signaling pathway Circ Res 112 2013 510 522
68. G. Spinetti, O. Fortunato, and A. Caporali et al. MicroRNA-15a and microRNA-16 impair human circulating proangiogenic cell functions and are increased in the proangiogenic cells and serum of patients with critical limb ischemia Circ Res 112 2013 335 346
69. A. Caporali, M. Meloni, and C. Vollenkle et al. Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia Circulation 123 2011 282 291
70. K.C. Vickers, B.T. Palmisano, B.M. Shoucri, R.D. Shamburek, and A.T. Remaley MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins Nat Cell Biol 13 2011 423 433
71. J. Wagner, M. Riwanto, and C. Besler et al. Characterization of levels and cellular transfer of circulating lipoprotein-bound microRNAs Arterioscler Thromb Vasc Biol 33 2013 1392 1400
72. A. Turchinovich, L. Weiz, A. Langheinz, and B. Burwinkel Characterization of extracellular circulating microRNA Nucleic Acids Res 39 2011 7223 7233
73. P. Diehl, A. Fricke, and L. Sander et al. Microparticles: major transport vehicles for distinct microRNAs in circulation Cardiovasc Res 93 2012 633 644
74. H. Valadi, K. Ekstrom, A. Bossios, M. Sjostrand, J.J. Lee, and J.O. Lotvall Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells Nat Cell Biol 9 2007 654 659
75. X. Huang, T. Yuan, and M. Tschannen et al. Characterization of human plasma-derived exosomal RNAs by deep sequencing BMC Genomics 14 2013 319
76. A. Zernecke, K. Bidzhekov, and H. Noels et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection Sci Signal 2 2009 ra81
77. S.F. Mause, and C. Weber Microparticles: protagonists of a novel communication network for intercellular information exchange Circ Res 107 2010 1047 1057
78. E. Hergenreider, S. Heydt, and K. Treguer et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs Nat Cell Biol 14 2012 249 256
79. J.N. Boeckel, C.E. Thome, D. Leistner, A.M. Zeiher, S. Fichtlscherer, and S. Dimmeler Heparin selectively affects the quantification of microRNAs in human blood samples Clin Chem 59 2013 1125 1127
80. H.C. de Boer, C. van Solingen, and J. Prins et al. Aspirin treatment hampers the use of plasma microRNA-126 as a biomarker for the progression of vascular disease Eur Heart J 34 2013 3451 3457
81. E. Cavarretta, G.A. Chiariello, and G. Condorelli Platelets, endothelium, and circulating microRNA-126 as a prognostic biomarker in cardiovascular diseases: per aspirin ad astra Eur Heart J 34 2013 3400 3402
82. P.S. Mitchell, R.K. Parkin, and E.M. Kroh et al. Circulating microRNAs as stable blood-based markers for cancer detection Proc Natl Acad Sci U S A 105 2008 10513 10518
83. O.B. Bleijerveld, Y.N. Zhang, and S. Beldar et al. Proteomics of plaques and novel sources of potential biomarkers for atherosclerosis Proteomics Clin Appl 7 2013 490 503
84. M. Mayr, A. Zampetaki, P. Willeit, J. Willeit, and S. Kiechl MicroRNAs within the continuum of postgenomics biomarker discovery Arterioscler Thromb Vasc Biol 33 2013 206 214
85. B. Vogel, A. Keller, and K.S. Frese et al. Multivariate miRNA signatures as biomarkers for non-ischaemic systolic heart failure Eur Heart J 34 2013 2812 2823
86. G.K. Wang, J.Q. Zhu, and J.T. Zhang et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans Eur Heart J 31 2010 659 666
87. J. Ai, R. Zhang, and Y. Li et al. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction Biochem Biophys Res Commun 391 2010 73 77
88. A. Zampetaki, P. Willeit, and L. Tilling et al. Prospective study on circulating microRNAs and risk of myocardial infarction J Am Coll Cardiol 60 2012 290 299
89. Y. D'Alessandra, P. Devanna, and F. Limana et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction Eur Heart J 31 2010 2765 2773
90. M.K. Gupta, C. Halley, and Z.H. Duan et al. miRNA-548c: a specific signature in circulating PBMCs from dilated cardiomyopathy patients J Mol Cell Cardiol 62 2013 131 141
91. R. Roncarati, C.V. Anselmi, and M.A. Losi et al. Circulating miR-29a, among other upregulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy J Am Coll Cardiol 63 2014 920 927
92. S. Fichtlscherer, A.M. Zeiher, and S. Dimmeler Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? Arterioscler Thromb Vasc Biol 31 2011 2383 2390
93. A. Zampetaki, S. Kiechl, and I. Drozdov et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes Circ Res 107 2010 810 817
94. C.M. Hindson, J.R. Chevillet, and H.A. Briggs et al. Absolute quantification by droplet digital PCR versus analog real-time PCR Nat Methods 10 2013 1003 1005
95. G.K. Geiss, R.E. Bumgarner, and B. Birditt et al. Direct multiplexed measurement of gene expression with color-coded probe pairs Nat Biotechnol 26 2008 317 325
96. S.P. Nana-Sinkam, and C.M. Croce Clinical applications for microRNAs in cancer Clin Pharmacol Ther 93 2013 98 104
97. A.J. Tijsen, Y.M. Pinto, and E.E. Creemers Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases Am J Physiol Heart Circ Physiol 303 2012 H1085 H1095
98. Y. Goren, M. Kushnir, B. Zafrir, S. Tabak, B.S. Lewis, and O. Amir Serum levels of microRNAs in patients with heart failure Eur J Heart Fail 14 2012 147 154
99. C. Bauters, R. Kumarswamy, and A. Holzmann et al. Circulating miR-133a and miR-423-5p fail as biomarkers for left ventricular remodeling after myocardial infarction Int J Cardiol 3 2013 1837 1840
100. M.F. Corsten, R. Dennert, and S. Jochems et al. Circulating microRNA-208b and microRNA-499 reflect myocardial damage in cardiovascular disease Circ Cardiovasc Genet 3 2010 499 506
101. Y. Cheng, N. Tan, and J. Yang et al. A translational study of circulating cell-free microRNA-1 in acute myocardial infarction Clin Sci (Lond) 119 2010 87 95
102. O. Gidlof, P. Andersson, J. van der Pals, M. Gotberg, and D. Erlinge Cardiospecific microRNA plasma levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are selectively dependent on renal elimination, and can be detected in urine samples Cardiology 118 2011 217 226
103. C. Liebetrau, H. Mollmann, and O. Dorr et al. Release kinetics of circulating muscle-enriched microRNAs in patients undergoing transcoronary ablation of septal hypertrophy J Am Coll Cardiol 62 2013 992 998
104. Y. Kuwabara, K. Ono, and T. Horie et al. Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage Circ Cardiovasc Genet 4 2011 446 454
105. I. Eitel, V. Adams, and P. Dieterich et al. Relation of circulating MicroRNA-133a concentrations with myocardial damage and clinical prognosis in ST-elevation myocardial infarction Am Heart J 164 2012 706 714
106. M. Jaguszewski, J. Osipova, and J.R. Ghadri et al. A signature of circulating microRNAs differentiates takotsubo cardiomyopathy from acute myocardial infarction Eur Heart J 35 2014 999 1006
107. X. Ji, R. Takahashi, Y. Hiura, G. Hirokawa, Y. Fukushima, and N. Iwai Plasma miR-208 as a biomarker of myocardial injury Clin Chem 55 2009 1944 1949
108. C. Widera, S.K. Gupta, and J.M. Lorenzen et al. Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome J Mol Cell Cardiol 51 2011 872 875
109. E. Goretti, M. Vausort, D.R. Wagner, and Y. Devaux Association between circulating microRNAs, cardiovascular risk factors and outcome in patients with acute myocardial infarction Int J Cardiol 168 2013 4548 4550
110. C. van Solingen, R. Bijkerk, H.C. de Boer, T.J. Rabelink, and A.J. van Zonneveld The role of microRNA-126 in vascular homeostasis Curr Vasc Pharmacol 2013 May 13 [E-pub ahead of print]
111. L. Kong, J. Zhu, and W. Han et al. Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study Acta Diabetol 48 2011 61 69
112. Y. Rong, W. Bao, and Z. Shan et al. Increased microRNA-146a levels in plasma of patients with newly diagnosed type 2 diabetes mellitus PLoS One 8 2013 e73272
113. E. van Rooij, and E.N. Olson MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles Nat Rev Drug Discov 11 2012 860 872
114. J. Krutzfeldt, N. Rajewsky, and R. Braich et al. Silencing of microRNAs in vivo with 'antagomirs' Nature 438 2005 685 689
115. J. Krutzfeldt, M.N. Poy, and M. Stoffel Strategies to determine the biological function of microRNAs Nat Genet 38 Suppl 2006 S14 S19
116. H.L. Janssen, H.W. Reesink, and E.J. Lawitz et al. Treatment of HCV infection by targeting microRNA N Engl J Med 368 2013 1685 1694
117. Y. Fukushima, M. Nakanishi, H. Nonogi, Y. Goto, and N. Iwai Assessment of plasma miRNAs in congestive heart failure Circ J 75 2011 336 340
118. A.J. Tijsen, E.E. Creemers, and P.D. Moerland et al. MiR423-5p as a circulating biomarker for heart failure Circ Res 106 2010 1035 1039
119. S. Matsumoto, Y. Sakata, and S. Suna et al. Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction Circ Res 113 2013 322 326
120. D.S. Zhao, Y. Chen, and H. Jiang et al. Serum miR-210 and miR-30a expressions tend to revert to fetal levels in Chinese adult patients with chronic heart failure Cardiovasc Pathol 22 2013 444 450
121. R. Roncarati, C. Viviani Anselmi, and M.A. Losi et al. Circulating miR-29 is a biomarker of hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy J Am Coll Cardiol 63 2014 920 927
122. T.G. Hullinger, R.L. Montgomery, and A.G. Seto et al. Inhibition of miR-15 protects against cardiac ischemic injury Circ Res 110 2012 71 81
123. J. Fiedler, V. Jazbutyte, and B.C. Kirchmaier et al. MicroRNA-24 regulates vascularity after myocardial infarction Circulation 124 2011 720 730
124. X.P. Ren, J. Wu, and X. Wang et al. MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20 Circulation 119 2009 2357 2366
125. R.L. Montgomery, T.G. Hullinger, and H.M. Semus et al. Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure Circulation 124 2011 1537 1547
126. A. Ucar, S.K. Gupta, and J. Fiedler et al. The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy Nat Commun 3 2012 1078
127. D.M. Patrick, R.L. Montgomery, and X. Qi et al. Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice J Clin Invest 120 2010 3912 3916
128. Y. Lu, Y. Zhang, and N. Wang et al. MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation Circulation 122 2010 2378 2387
129. R. Ji, Y. Cheng, and J. Yue et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation Circ Res 100 2007 1579 1588
130. K.J. Rayner, C.C. Esau, and F.N. Hussain et al. Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides Nature 478 2011 404 407
131. L. Maegdefessel, J. Azuma, and R. Toh et al. Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development J Clin Invest 122 2012 497 506
132. R.A. Boon, T. Seeger, and S. Heydt et al. MicroRNA-29 in aortic dilation: implications for aneurysm formation Circ Res 109 2011 1115 1119
133. Q. Zhou, R. Gallagher, R. Ufret-Vincenty, X. Li, E.N. Olson, and S. Wang Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23∼27∼24 clusters Proc Natl Acad Sci U S A 108 2011 8287 8292
134. S. Sepramaniam, A. Armugam, and K.Y. Lim et al. MicroRNA 320a functions as a novel endogenous modulator of aquaporins 1 and 4 as well as a potential therapeutic target in cerebral ischemia J Biol Chem 285 2010 29223 29230
135. M.F. Corsten, A. Papageorgiou, and W. Verhesen et al. MicroRNA profiling identifies microRNA-155 as an adverse mediator of cardiac injury and dysfunction during acute viral myocarditis Circ Res 111 2012 415 425